Mevacor labeling
Executive Summary
Recommendation that patients taking Merck's cholesterol-lowering drug receive yearly slitlamp eye examinations has been removed from the drug's labeling. The recommendation was originally included in labeling because new eye opacities appeared in patients enrolled in clinical trials....